alendronate has been researched along with Neutropenia in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current study was undertaken to investigate the effect of alendronate on bone mineral density (BMD), bone metabolism markers, and serum bone-resorbing cytokines in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis." | 9.11 | Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. ( Christoforidou, A; Eliopoulos, GD; Malliaraki, N; Margioris, AN; Miliaki, M; Papadaki, HA; Pontikoglou, C; Psyllaki, M; Tsatsanis, C, 2004) |
| "The current study was undertaken to investigate the effect of alendronate on bone mineral density (BMD), bone metabolism markers, and serum bone-resorbing cytokines in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis." | 5.11 | Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. ( Christoforidou, A; Eliopoulos, GD; Malliaraki, N; Margioris, AN; Miliaki, M; Papadaki, HA; Pontikoglou, C; Psyllaki, M; Tsatsanis, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadaki, HA | 1 |
| Tsatsanis, C | 1 |
| Christoforidou, A | 1 |
| Malliaraki, N | 1 |
| Psyllaki, M | 1 |
| Pontikoglou, C | 1 |
| Miliaki, M | 1 |
| Margioris, AN | 1 |
| Eliopoulos, GD | 1 |
1 trial available for alendronate and Neutropenia
| Article | Year |
|---|---|
Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Diseases, Metabolic; Chronic Disease; Femal | 2004 |